Pharmaceutical - GlaxoSmithKline, Legal


Current filters:


Popular Filters

1 to 25 of 28 results

GSK spies indicted in China for illegally obtaining information

GSK spies indicted in China for illegally obtaining information


A couple allegedly working for UK pharma major GlaxoSmithKline in China have been indicted in Shanghai…

ChinaGlaxoSmithKlineGSKLegalPharmaceuticalXinhua News AgencyXinhua News Agency

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states


UK pharma giant GlaxoSmithKline has agreed to a $105 million settlement with 44 US states and the District…

AdvairFinancialGlaxoSmithKlineLegalMarkets & MarketingNeurologicalPaxilPharmaceuticalRespiratory and PulmonaryUSAWellbutrin

GlaxoSmithKline now faces UK SFO inquiry into commercial practices

GlaxoSmithKline now faces UK SFO inquiry into commercial practices


UK pharma giant GlaxoSmithKline, already subject to allegations of bribery of doctors and hospitals in…

GlaxoSmithKlineLegalMarkets & MarketingPharmaceuticalUK

GlaxoSmithKline now accused of tax evasion in China


The Legal Daily, the official newspaper of the Chinese Ministry of Justice, on Friday accused UK pharma…


Police close investigation on GlaxoSmithKline China's bribery case

Police close investigation on GlaxoSmithKline China's bribery case


Chinese police have finished the investigation on the suspected bribery case of the local subsidiary…

ChinaGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

GSK faces bribery allegations in Poland

GSK faces bribery allegations in Poland


UK pharma major GlaxoSmithKline is facing allegations of bribing doctors in Poland, according to the…

BBCGlaxoSmithKlineGSK regional managerLegalMajorMedicinePharmaceuticalPolandPulmonologyRespiratory and PulmonarySeretideUK

Report: Health care companies lead the way in corporate compliance


Health care companies are leading the way in terms of public trust and transparency, according to The…

AstraZenecaGlaxoSmithKlineLegalManagementPharmaceuticalReckitt BenckiserUK

US Appeals Court reverses 2012 decision on Lovaza, clearing way for generics


Reversing a district court decision last year (The Pharma Letter May 30, 2012), the US Court of Appeals…

AmarinCardio-vascularGenericsGlaxoSmithKlineLegalLovazaNorth AmericaPar PharmaceuticalsPatentsPharmaceuticalTeva Pharmaceutical IndustriesVascepa

AHF sues GSK for failing to provide discounts on HIV/AIDS drugs


The USA-based AIDS Healthcare Foundation (AHF) said yesterday (September 10) that it has filed a law…

Anti-viralsGlaxoSmithKlineLegalNorth AmericaPharmaceuticalPricing

GlaxoSmithKline could be considering quitting China, says BBC editor


For most multinational companies, it is a no-brainer that they have to be big in China, if their global…

Asia-PacificGlaxoSmithKlineLegalManagementMarkets & MarketingPharmaceutical

Chinese police reveal more on GSK China's suspected violations


The Chinese police have recently revealed more details about suspected economic violations by UK pharma…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

Another blow for Pharma, as India revokes Tykerb patent


UK pharma giant GlaxoSmithKline (LSE: GSK) has confirmed that India's Intellectual Property Appellate…


More details emerge of GSK China bribery allegations


The extent of the alleged bribery and tax-related violations by UK pharma major GlaxoSmithKline (LSE:…


Investigation on-going as claims GSK staff may have broken Chinese law


Sales staff at UK pharma major GlaxoSmithKline (LSE: GSK) in China may have broken Chinese law, the company…


China says GSK probe part of business climate clean-up


China's probe into UK pharma major GlaxoSmithKline (LSE: GSK) was part of the country's efforts to improve…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

US Court denies re-hearing of Arzerra patent case


Danish drugmaker Genmab (OMX: GEN) says that the US Court of Appeals for the Federal Circuit has declined…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceutical

China probe into GlaxoSmithKline bribery allegations escalates


Investigations in China relating to alleged bribery and tax-related crimes by UK pharma giant GlaxoSmithKline…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

UK's OFT accuses GlaxoSmithKline of "market abuse"


The UK's Office of Fair Trading (OFT) today (April 19) issued a Statement of Objections to certain pharmaceutical…

AlpharmaEuropeGenericsGlaxoSmithKlineLegalMarkets & MarketingNeurologicalNorton HealthcarePaxilPharmaceuticalPricingSeroxat

News briefs on Sanofi, Novo Nordisk and GlaxoSmithKline/Amicus


Two US subsidiaries of French drug major Sanofi (Euronext: SAN) have agreed to pay $109 million to resolve…

Amicus TherapeuticsAmigalDiabetesFIAspFinancialGlaxoSmithKlineHyalganIDegLiraLegalNorth AmericaNovo NordiskPharmaceuticalRare diseasesResearchSanofi

GSK settlement still not enough to deter Pharma, says Public Citizen


This week's announcement of the largest health fraud settlement ever reached between a pharmaceutical…

FinancialGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

GlaxoSmithKline to plead guilty and pay record $3 billion to resolve US fraud allegations


UK pharma giant GlaxoSmithKline (LSE: GSK) has agreed to plead guilty and to pay $3 billion - the largest…

FinancialGlaxoSmithKlineLegalMarkets & MarketingNorth AmericaPharmaceutical

1 to 25 of 28 results




Back to top